← Back to Search

Electronic Cigarette

Menthol-Flavored E-Cigarettes for Smoking Cessation

N/A
Recruiting
Led By Nicole Nollen, PhD
Research Sponsored by Nikki Nollen, PhD, MA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥ 21 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

Study Summary

This trial will test if menthol-flavored e-cigarettes help adult menthol smokers switch from cigarettes to vaping more than tobacco-flavored ones.

Who is the study for?
This trial is for adult menthol smokers who smoke at least 5 cigarettes daily, have been smoking menthol cigarettes for over 6 months, and are interested in switching to e-cigarettes. They must be over 21 with a functioning phone. People can't join if they've used e-cigarettes or smoking cessation aids recently, have uncontrolled high blood pressure, are pregnant/breastfeeding, plan to move away soon, or want to quit smoking.Check my eligibility
What is being tested?
The study is testing whether using menthol-flavored or tobacco-flavored nicotine salt-based pod-system e-cigarettes helps adult menthol smokers switch from regular cigarettes to e-cigarettes more effectively.See study design
What are the potential side effects?
Potential side effects of using electronic cigarettes may include throat irritation, coughing, dry mouth and increased addiction potential due to nicotine content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants who switch from cigarettes to electronic cigarettes at Week 12
Secondary outcome measures
Amount of e-liquid consumed
Spirometry

Trial Design

2Treatment groups
Active Control
Group I: Menthol Flavor Electronic CigaretteActive Control1 Intervention
400 adult cigarette smokers will receive 12 weeks of menthol-flavored electronic cigarettes.
Group II: Tobacco Flavor Electronic CigaretteActive Control1 Intervention
400 adult cigarette smokers will receive 12 weeks of tobacco-flavored electronic cigarettes.

Find a Location

Who is running the clinical trial?

Nikki Nollen, PhD, MALead Sponsor
2 Previous Clinical Trials
521 Total Patients Enrolled
Nicole Nollen, PhDPrincipal InvestigatorUniversity of Kanas Medical Center
3 Previous Clinical Trials
964 Total Patients Enrolled

Media Library

Menthol-flavored electronic cigarette (Electronic Cigarette) Clinical Trial Eligibility Overview. Trial Name: NCT05555069 — N/A
Smoking Cessation Research Study Groups: Menthol Flavor Electronic Cigarette, Tobacco Flavor Electronic Cigarette
Smoking Cessation Clinical Trial 2023: Menthol-flavored electronic cigarette Highlights & Side Effects. Trial Name: NCT05555069 — N/A
Menthol-flavored electronic cigarette (Electronic Cigarette) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05555069 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts still ongoing for this investigation?

"This experiment is currently accepting participants, as confirmed by the clinicaltrials.gov website where it was first uploaded on 8th November 2022 and its details last revised on 10th February 2023."

Answered by AI

How many participants are currently receiving treatment in this experiment?

"Indeed, the information available on clinicaltrials.gov confirms that this medical study is actively recruiting participants; it was first announced on November 8th 2022 and its most recent update occurred on February 10th 2023. The research requires 800 individuals from one medical centre to take part in the trial."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

Well, for the most part, I am a healthy 41. Year old woman with alot of spare time on my hands but I am a cigarette smoker. And I was just interested. A friend told me about the clinical trials.
PatientReceived 2+ prior treatments
~361 spots leftby Jun 2025